Advertisement

Reactions Weekly

, Volume 1658, Issue 1, pp 187–187 | Cite as

Erlotinib/gefitinib

Hepatotoxicity and arthritis: 2 case reports
Case report
  • 24 Downloads

Reference

  1. Guerreiro I, et al. TKI as first line treatment in advanced non-small-cell lung cancer with EGFR mutations. Journal of Thoracic Oncology 12 (Suppl. 1): S1244-S1245 abstr. P3.02b-088, Jan 2017 [abstract] - PortugalGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations